CAVIN1 and prostate carcinoma: To confirm the antiangiogenic and antilymphangiogenic activities of PTRF in vivo, we used an orthotopic prostate cancer xenograft mouse model previously employed to show that PTRF expression in PC3 cells reduces in vivo tumor growth and metastasis [21].